Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-02 · accession 0002001162-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-04 | 2026-02-02 | IPSC | Pfeiffenberger Brent | Pres, CEO, Dir | A - Grant | $0.00 | +475.0K | 3.80M | +14% | $0 |
| D | 2026-02-04 | 2026-02-02 | IPSC | Pfeiffenberger Brent | Pres, CEO, Dir | A - Grant | $0.00 | +945.0K | 945.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | A | A | 475,000 | $0.00 | 3,797,990 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2026-02-02 | A | A | 945,000 | $0.00 | 945,000 | D | $1.84 · — to 2036-02-02 | 945,000 Common Stock | (F2) The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. |